Experienced in Nephrectomy

Dr. Matthew J. Krasin

Radiation Oncology
262 Danny Thomas Pl, 
Memphis, TN 
Accepting New Patients
Offers Telehealth
Experienced in Nephrectomy
262 Danny Thomas Pl, 
Memphis, TN 
OverviewInsuranceLocationsClinical Research

Overview

Matthew Krasin is a Radiation Oncologist in Memphis, Tennessee. Dr. Krasin is rated as an Experienced provider by MediFind in Nephrectomy. His top areas of expertise are Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Embryonal Tumor with Multilayered Rosettes, Nephrectomy, and Thrombectomy. Dr. Krasin is currently accepting new patients.

His clinical research consists of co-authoring 124 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Nephrectomy.

Specialties
Radiation Oncology
Licenses
Radiology in TN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO

Locations

262 Danny Thomas Pl, Memphis, TN 38105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: February 18, 2025
Intervention Type: Drug, Procedure
Study Drugs: Vincristine, Dactinomycin, Cyclophosphamide, Bevacizumab, Sorafenib, Myeloid growth factor, Irinotecan, Ifosfamide, Etoposide, Etoposide phosphate, Doxorubicin, Dexrazoxane, ^1^1C-methionine
Study Phase: Phase 2
A Phase II Study of Hyperfractionated Stereotactic Radiotherapy in the Treatment of Metastatic Pediatric Sarcomas of Bony Sites
A Phase II Study of Hyperfractionated Stereotactic Radiotherapy in the Treatment of Metastatic Pediatric Sarcomas of Bony Sites
Enrollment Status: Completed
Publish Date: August 27, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
View 1 Less Clinical Trial

122 Total Publications

One-Two Punch: Combining Chemotherapy and Immunotherapy to Decrease Radiation Dose and Related Toxicity in Children and Adolescents with Nasopharyngeal Carcinoma.
One-Two Punch: Combining Chemotherapy and Immunotherapy to Decrease Radiation Dose and Related Toxicity in Children and Adolescents with Nasopharyngeal Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 07, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krasin's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile